QIBA logo FIN.jpg

 

 

 

 

 

 

 

Quantitative Imaging Biomarkers Alliance (QIBA) Annual Meeting

May 15-16, 2018

RSNA Headquarters, Oak Brook, IL

 

Day 1: Tuesday, May 15, 2018

12:00 PM

Lunch

1:00 PM

General Meeting Welcome; Logistics

Alexander Guimaraes, MD, PhD and Linda Bresolin, PhD, MBA, CAE

1:10 PM

Current Status of QIBA

Edward Jackson, PhD – QIBA Chair Vice-chair

1:30 PM

Panel Discussion: Advancing QIBA Profiles to “Claim Confirmed” Stage: FDG-PET/CT Example

Moderated Panel (Richard Wahl, MD) Rathan Subramaniam, MD, PhD; Paul Kinahan, PhD; John Sunderland, PhD; Scott Wollenweber, PhD; and Nancy Obuchowski, PhD

2:00 PM

Plenary Session 1: Machine Learning, AI, and Radiomics – What Is The Role for QI?

Maryellen Giger, PhD – University of Chicago

 

2:30 PM

Plenary Session 2: The “Value Add” of Quantitative Imaging in Clinical Trials

Mark J. Ratain, MD – University of Chicago

 

3:00 PM

Panel Discussion: How Should Quantitative Imaging Become Integrated Into Radiology Practice?

Moderated Panel (Alexander Guimaraes, MD, PhD)

 

3:30 PM

External Liaison Report and International Collaborations Updates

Daniel Sullivan, MD, Xavier Golay, PhD – EIBALL, and Ukihide Tateishi, PhD – QIBA-Japan

 

4:00 PM

Break and Start of Concurrent Biomarker Committee Sessions (Day 1)

 

 

·      CT Modality Session (2nd Floor Conference Room)

 

 

·      MR Modality Session (3rd Floor Library)

 

 

·      NM Modality Session (4th Floor Conference Room)

 

 

·      US Modality Session (1st Floor Executive Conference Room)

 

6:00 PM

Adjourn

 

6:15 PM

Reception

 

 

Day 2: Wednesday, May 16, 2018

7:15 AM

Breakfast

8:00 AM

Coordinating Committee Updates (Modality Dashboards)

 

 

·      CT Coordinating Committee

 

·      MR Coordinating Committee

 

 

·      NM Coordinating Committee

 

·      US Coordinating Committee

 

9:20 AM

Plenary Session 3: The “Value Add” of Quantitative Imaging in the Assessment and Treatment of Brain Disorders

Ranga Krishnan, MD, ChB – Rush Medical College

 

9:50 AM

Break

 

10:10 AM

Profile Conformance Process and Feasibility Test Examples

John Sunderland, PhD (FDG-PET/CT), Andrew Buckler, MS (CT Volumetry), and Ricardo Avila, MS (CT Small Lung Nodule)

 

11:10 AM

Process Committee Report and Discussion

Kevin O’Donnell, MASc

 

11:40 AM

QIBA Sustainability – Prioritized Options for QIBA’s Evolution

Annette Schmid, PhD

 

12:10 PM

Lunch

 

12:40 PM

Concurrent Biomarker Committee Sessions (Day 2)

 

 

·      CT Modality Session (2nd Floor Conference Room)

 

 

·      MR Modality Session (3rd Floor Library)

 

 

·      NM Modality Session (4th Floor Conference Room)

 

·      US Modality Session (1st Floor Executive Conference Room)

 

4:00 PM

Adjourn

 

 

QIBA Annual Meeting Roster

 

 

Breakout Group Sessions Roster